Soleno Therapeutics, Inc. (SLNO)

Soleno Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	42.85	169.68	14.6	21.3	49.22	20.73
Short-Term Investments	106.78	0	0	0	0	0
Cash & Cash Equivalents	149.63	169.68	14.6	21.3	49.22	20.73
Cash Growth	1800.27%	1062.04%	-31.46%	-56.72%	137.42%	-13.89%
Other Current Assets	1.6	1.68	1.05	1.12	1.02	0.41
Total Current Assets	151.22	171.36	15.65	22.42	50.24	21.14
Property, Plant & Equipment	0.37	0.42	0.16	0.45	0.16	0.44
Long-Term Investments	8.82	0	0	0	0	0
Goodwill and Intangibles	8.26	8.75	10.69	12.64	14.58	16.53
Other Long-Term Assets	0.17	0.17	0	0.04	0	0.06
Total Long-Term Assets	17.61	9.33	10.85	13.13	14.74	17.03
Total Assets	168.84	180.69	26.5	35.55	64.98	38.17
Accounts Payable	8.02	3.15	1.78	3.25	3.49	2
Current Debt	0.31	0.27	0.16	0.28	0.14	0.31
Other Current Liabilities	5.13	8.08	5.38	4.47	4.99	2.66
Total Current Liabilities	13.46	11.51	7.31	8.01	8.62	4.96
Long-Term Debt	0.04	0.13	0	0.18	0	0
Other Long-Term Liabilities	11.95	11.55	8.84	9.58	10.82	18.26
Total Long-Term Liabilities	11.99	11.68	8.84	9.75	10.82	18.26
Total Liabilities	25.45	23.18	16.15	17.76	19.44	23.23
Total Debt	0.35	0.4	0.16	0.46	0.14	0.31
Debt Growth	789.74%	160.00%	-66.08%	228.78%	-54.43%	-
Retained Earnings	-297.81	-276.41	-237.42	-213.36	-182.45	-157.81
Comprehensive Income	-0.11	0	0	0	0	0
Shareholders' Equity	143.39	157.51	10.35	17.79	45.55	14.95
Net Cash / Debt	149.28	169.28	14.45	20.85	49.09	20.43
Net Cash / Debt Growth	1805.30%	1071.72%	-30.70%	-57.53%	140.28%	-15.16%
Net Cash Per Share	4.12	10.26	1.72	3.92	11.76	8.97
Working Capital	137.76	159.85	8.33	14.42	41.63	16.18
Book Value Per Share	3.96	9.55	1.23	3.35	10.91	6.57

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).